- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hologic, Del Global strike DR deal
Del Global has licensed the rights and trademarks to digital radiography systems originally developed, manufactured, and marketed by Hologic. The agreement between the two companies paves the way for Del Global to begin manufacturing the
Del Global has licensed the rights and trademarks to digital radiography systems originally developed, manufactured, and marketed by Hologic. The agreement between the two companies paves the way for Del Global to begin manufacturing the direct-to-digital general radiography systems under the Epex, Epex ER, DR1000, Omniflex, and Radex brand names. Hologic will support the transfer of manufacturing from its Bedford, MA, facility to a Del facility in Chicago. Also in collaboration with Del, Hologic will provide ongoing service support to customers, as well as its DirectRay detector for integration into Del's finished products. The licensing agreement reflects a strategic shift by Hologic management away from manufacturing finished digital radiography equipment for sale to end users in favor of supplying digital detectors to OEMs.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
